NCT03654170View on ClinicalTrials.gov

A Study in Healthy Men to Find Out How BI 425809 is Taken up and Handled by the Body

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

September 11, 2018

Primary Completion Date

November 12, 2018

Study Completion Date

November 12, 2018

Conditions
Healthy
Interventions
DRUG

BI 425809 mixed with [C-14] BI425809

Oral Solution

Trial Locations (1)

9728 NZ

PRA Health Sciences Onderzoekscentrum Martini, Groningen

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT03654170 - A Study in Healthy Men to Find Out How BI 425809 is Taken up and Handled by the Body | Biotech Hunter | Biotech Hunter